Loading organizations...

Heal Capital is a venture capital firm investing in early-stage European HealthTech companies. It provides capital and direct access to healthcare systems, targeting Pre-Seed to Series A rounds, with investments typically ranging from €1 million to €5 million. The firm supports innovators developing solutions to transform delivery and patient outcomes.
Established in 2019, Heal Capital was co-founded by Eckhardt Weber, Managing Partner, and Peter Wibbe, Founding Partner. Their insight recognized a critical need for specialized financial backing and industry integration for nascent HealthTech ventures. This led to a model designed to bridge innovation and effective market penetration.
Heal Capital primarily serves mission-driven founders creating technology to advance healthcare. The company's long-term vision centers on fostering a robust HealthTech innovation ecosystem across Europe. Through active engagement, Heal Capital aims to significantly shape healthcare's future, improving efficiency, accessibility, and quality of care.
Key people at Heal Capital.
Heal Capital was founded in 2019 by Eckhardt Weber (Co-Founder and Managing Partner).
Heal Capital was founded in 2019 by Eckhardt Weber (Co-Founder and Managing Partner).
Key people at Heal Capital.
Heal Capital is a Berlin-based venture capital firm founded in 2019, dedicated to transforming healthcare through technology. Its mission is to back mission-driven founders who are redefining healthcare delivery by investing in startups that bridge the gap between digital innovation and patient care. The firm specializes in technology-enabled healthcare, focusing on vertically integrated micro-providers (VIMPROs) and solutions that address underserved problems in the healthcare system. Heal Capital invests from Pre-Seed to Series A stages, typically writing checks between €1 million and €5 million, and leverages its deep connections with over 25 German private health insurers—including Allianz, Axa, and DKV—to provide portfolio companies with immediate access to healthcare networks and real-world validation.
By supporting startups that improve patient engagement, outcomes, and operational efficiency, Heal Capital has become a key player in Europe’s HealthTech ecosystem. Its investments are not only financial but also strategic, helping founders navigate regulatory landscapes, scale rapidly, and integrate with established healthcare providers.
---
Heal Capital was founded in 2019 by a team of healthcare and investment professionals, including Christian Lautner and Eckhardt Weber, who recognized the urgent need for innovation in Europe’s healthcare system. The firm emerged at a time when digital health was gaining momentum, but access to capital and healthcare infrastructure remained a major barrier for startups. Heal Capital’s unique structure—backed by a consortium of leading German private health insurers—was designed to address this gap, enabling founders to secure both funding and operational support from day one.
Since its launch, Heal Capital has raised over €100 million (with some sources citing a total investment volume exceeding €200 million), establishing itself as one of Europe’s leading dedicated HealthTech funds. The firm’s evolution has been marked by a growing portfolio of startups that are reshaping how care is delivered, from digital therapeutics to AI-driven diagnostics and patient engagement platforms.
---
---
Heal Capital is riding the wave of digital transformation in healthcare, a trend accelerated by the global pandemic and increasing demand for accessible, efficient, and patient-centered care. The firm is positioned at the intersection of technology and healthcare, supporting startups that leverage AI, data analytics, and digital platforms to solve systemic challenges. By focusing on vertically integrated solutions, Heal Capital is helping to create a new generation of healthcare providers that are more agile, responsive, and scalable than traditional models.
The timing is critical: as healthcare systems worldwide face mounting pressure to innovate, Heal Capital’s model—combining venture capital with direct access to healthcare infrastructure—gives its portfolio companies a significant competitive advantage. The firm’s influence extends beyond individual startups, shaping the broader HealthTech ecosystem by setting new standards for how technology and care delivery can be integrated.
---
Heal Capital is poised to play an increasingly influential role in Europe’s HealthTech landscape as the demand for digital health solutions continues to grow. The firm’s unique combination of capital, network, and operational support positions it to back the next wave of healthcare innovators, from AI-driven diagnostics to personalized medicine and remote care platforms. As regulatory frameworks evolve and healthcare systems embrace digital transformation, Heal Capital’s model could serve as a blueprint for how venture capital can drive meaningful change in one of the world’s most complex industries.
Looking ahead, the firm is likely to expand its portfolio into adjacent areas such as mental health, aging populations, and preventive care, while deepening its partnerships with insurers and healthcare providers. Heal Capital’s journey reflects a broader shift in venture capital: from simply funding startups to actively shaping the future of entire industries.